During
the three and six months ended June 30, 2025, the Company awarded the following under the 2021 Plan:
Schedule
of Restricted Stock Share Based Compensation
Award Type | |
Number of Awards | | |
Fair Value/Closing Market Price at Grant | |
| |
| | |
| |
Restricted Stock Awards – Common Stock | |
| 2,140,683 | | |
$ | 0.64 | |
Restricted Stock Units – Common Stock | |
| 32,000 | | |
$ | 0.63 | |
| |
| 2,172,683 | | |
| | |
During
the three and six months ended June 30, 2024, the Company awarded the following under the 2021 Plan:
Award Type | |
Number of Awards | | |
Fair Value/Closing Market Price at Grant | |
| |
| | |
| |
Restricted Stock Awards – Common Stock | |
| 391,544 | | |
$ | 1.52 | |
Restricted Stock Awards – Common Stock | |
| 90,734 | | |
$ | 2.41 | |
Restricted Stock Awards – Preferred A Stock | |
| 1,892,300 | | |
$ | 2.50 | |
| |
| 2,374,578 | | |
| | |
During
the three and six months ended June 30, 2024, the Company awarded the following under the 2023 Plan:
Award Type | |
Number of Awards | | |
Fair Value/Closing Market Price at Grant | |
| |
| | |
| |
Restricted Stock Awards – Common Stock | |
| 610,234 | | |
$ | 1.52 | |
Restricted Stock Awards – Common Stock | |
| 57,255 | | |
$ | 2.41 | |
| |
| 667,489 | | |
| | |
|